Literature DB >> 19471311

Novel SOX2 partner-factor domain mutation in a four-generation family.

Marija Mihelec1, Peter Abraham, Kate Gibson, Renata Krowka, Rachel Susman, Rebecca Storen, Yongjuan Chen, Jenny Donald, Patrick P L Tam, John R Grigg, Maree Flaherty, Glen A Gole, Robyn V Jamieson.   

Abstract

Anophthalmia (no eye), microphthalmia (small eye) and associated ocular developmental anomalies cause significant visual handicap. In most cases the underlying genetic cause is unknown, but mutations in some genes, such as SOX2, cause ocular developmental defects, particularly anophthalmia, in a subset of patients. Here, we describe a four-generation family with a p.Asp123Gly mutation in the highly conserved partner-factor interaction region of the SOX2 protein, which is important for cell-specific actions of SOX2. The proband in this family has bilateral anophthalmia and several other family members have milder ocular phenotypes, including typical optic fissure coloboma. Expression studies indicate that Sox2 is expressed in the eye at the site of closure of the optic fissure during development. The SOX2 mutation in this family implicates the partner-factor interaction region of SOX2 in contributing to the specificity of SOX2 action in optic fissure closure. Our findings indicate that investigation of SOX2 in a broad range of eye anomaly patients aids in the determination of particular functions of SOX2 in development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19471311      PMCID: PMC2986670          DOI: 10.1038/ejhg.2009.79

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  22 in total

1.  Anophthalmia-esophageal atresia syndrome caused by an SOX2 gene deletion in monozygotic twin brothers with markedly discordant phenotypes.

Authors:  Juan Carlos Zenteno; Hector J Perez-Cano; Monica Aguinaga
Journal:  Am J Med Genet A       Date:  2006-09-15       Impact factor: 2.802

2.  The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2.

Authors:  M Nishimoto; A Fukushima; A Okuda; M Muramatsu
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

3.  BMP4 is essential for lens induction in the mouse embryo.

Authors:  Y Furuta; B L Hogan
Journal:  Genes Dev       Date:  1998-12-01       Impact factor: 11.361

4.  PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects.

Authors:  T Glaser; L Jepeal; J G Edwards; S R Young; J Favor; R L Maas
Journal:  Nat Genet       Date:  1994-08       Impact factor: 38.330

5.  SOX2 anophthalmia syndrome.

Authors:  Nicola K Ragge; Birgit Lorenz; Adele Schneider; Kate Bushby; Luisa de Sanctis; Ugo de Sanctis; Alison Salt; J Richard O Collin; Anthony J Vivian; Samantha L Free; Pamela Thompson; Kathleen A Williamson; Sanjay M Sisodiya; Veronica van Heyningen; David R Fitzpatrick
Journal:  Am J Med Genet A       Date:  2005-05-15       Impact factor: 2.802

6.  Heterozygous mutations of OTX2 cause severe ocular malformations.

Authors:  Nicola K Ragge; Alison G Brown; Charlotte M Poloschek; Birgit Lorenz; R Alex Henderson; Michael P Clarke; Isabelle Russell-Eggitt; Alistair Fielder; Dianne Gerrelli; Juan Pedro Martinez-Barbera; Piers Ruddle; Jane Hurst; J Richard O Collin; Alison Salt; Simon T Cooper; Pamela J Thompson; Sanjay M Sisodiya; Kathleen A Williamson; David R Fitzpatrick; Veronica van Heyningen; Isabel M Hanson
Journal:  Am J Hum Genet       Date:  2005-04-21       Impact factor: 11.025

7.  Recurrence of SOX2 anophthalmia syndrome with gonosomal mosaicism in a phenotypically normal mother.

Authors:  Laurence Faivre; Kathleen A Williamson; Valérie Faber; Nicole Laurent; Marianne Grimaldi; Christel Thauvin-Robinet; Christine Durand; Francine Mugneret; Jean-Bernard Gouyon; Alain Bron; Frédéric Huet; Caroline Hayward; Veronica van Heyningen; David R Fitzpatrick
Journal:  Am J Med Genet A       Date:  2006-03-15       Impact factor: 2.802

8.  Comparative expression of the mouse Sox1, Sox2 and Sox3 genes from pre-gastrulation to early somite stages.

Authors:  H B Wood; V Episkopou
Journal:  Mech Dev       Date:  1999-08       Impact factor: 1.882

9.  Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans.

Authors:  Daniel Kelberman; Karine Rizzoti; Ariel Avilion; Maria Bitner-Glindzicz; Stefano Cianfarani; Julie Collins; W Kling Chong; Jeremy M W Kirk; John C Achermann; Richard Ross; Danielle Carmignac; Robin Lovell-Badge; Iain C A F Robinson; Mehul T Dattani
Journal:  J Clin Invest       Date:  2006-08-24       Impact factor: 14.808

10.  Mutations in SOX2 cause anophthalmia-esophageal-genital (AEG) syndrome.

Authors:  Kathleen A Williamson; Ann M Hever; Joe Rainger; R Curtis Rogers; Alex Magee; Zdenek Fiedler; Wee Teik Keng; Freddie H Sharkey; Niolette McGill; Clare J Hill; Adele Schneider; Mario Messina; Peter D Turnpenny; Judy A Fantes; Veronica van Heyningen; David R FitzPatrick
Journal:  Hum Mol Genet       Date:  2006-03-16       Impact factor: 6.150

View more
  12 in total

Review 1.  Eye development genes and known syndromes.

Authors:  Anne M Slavotinek
Journal:  Mol Genet Metab       Date:  2011-09-29       Impact factor: 4.797

Review 2.  Conserved genetic pathways associated with microphthalmia, anophthalmia, and coloboma.

Authors:  Linda M Reis; Elena V Semina
Journal:  Birth Defects Res C Embryo Today       Date:  2015-06-03

Review 3.  Genetics of anterior segment dysgenesis disorders.

Authors:  Linda M Reis; Elena V Semina
Journal:  Curr Opin Ophthalmol       Date:  2011-09       Impact factor: 3.761

4.  Isolated hypogonadotropic hypogonadism with SOX2 mutation and anophthalmia/microphthalmia in offspring.

Authors:  Zornitza Stark; Rebecca Storen; Bruce Bennetts; Ravi Savarirayan; Robyn V Jamieson
Journal:  Eur J Hum Genet       Date:  2011-02-16       Impact factor: 4.246

5.  Exome sequencing in developmental eye disease leads to identification of causal variants in GJA8, CRYGC, PAX6 and CYP1B1.

Authors:  Ivan Prokudin; Cas Simons; John R Grigg; Rebecca Storen; Vikrant Kumar; Zai Y Phua; James Smith; Maree Flaherty; Sonia Davila; Robyn V Jamieson
Journal:  Eur J Hum Genet       Date:  2013-11-27       Impact factor: 4.246

6.  Examination of SOX2 in variable ocular conditions identifies a recurrent deletion in microphthalmia and lack of mutations in other phenotypes.

Authors:  Linda M Reis; Rebecca C Tyler; Adele Schneider; Tanya Bardakjian; Elena V Semina
Journal:  Mol Vis       Date:  2010-04-28       Impact factor: 2.367

7.  Review of 37 patients with SOX2 pathogenic variants collected by the Anophthalmia/Microphthalmia Clinical Registry and DNA research study.

Authors:  Louise Amlie-Wolf; Tanya Bardakjian; Sarina M Kopinsky; Linda M Reis; Elena V Semina; Adele Schneider
Journal:  Am J Med Genet A       Date:  2021-09-25       Impact factor: 2.578

8.  Heterozygous loss-of-function mutations in YAP1 cause both isolated and syndromic optic fissure closure defects.

Authors:  Kathleen A Williamson; Joe Rainger; James A B Floyd; Morad Ansari; Alison Meynert; Kishan V Aldridge; Jacqueline K Rainger; Carl A Anderson; Anthony T Moore; Matthew E Hurles; Angus Clarke; Veronica van Heyningen; Alain Verloes; Martin S Taylor; Andrew O M Wilkie; David R Fitzpatrick
Journal:  Am J Hum Genet       Date:  2014-01-23       Impact factor: 11.025

9.  Clinical and mutation analysis of 51 probands with anophthalmia and/or severe microphthalmia from a single center.

Authors:  Christina Gerth-Kahlert; Kathleen Williamson; Morad Ansari; Jacqueline K Rainger; Volker Hingst; Theodor Zimmermann; Stefani Tech; Rudolf F Guthoff; Veronica van Heyningen; David R Fitzpatrick
Journal:  Mol Genet Genomic Med       Date:  2013-03-27       Impact factor: 2.183

10.  Sox11 is required to maintain proper levels of Hedgehog signaling during vertebrate ocular morphogenesis.

Authors:  Lakshmi Pillai-Kastoori; Wen Wen; Stephen G Wilson; Erin Strachan; Adriana Lo-Castro; Marco Fichera; Sebastiano A Musumeci; Ordan J Lehmann; Ann C Morris
Journal:  PLoS Genet       Date:  2014-07-10       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.